Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

CD100 on NK cells enhance IFNgamma secretion and killing of target cells expressing CD72.

Mizrahi S, Markel G, Porgador A, Bushkin Y, Mandelboim O.

PLoS One. 2007 Sep 5;2(9):e818.

2.
3.

B-cell co-receptor CD72 is expressed on NK cells and inhibits IFN-gamma production but not cytotoxicity.

Alcón VL, Luther C, Balce D, Takei F.

Eur J Immunol. 2009 Mar;39(3):826-32. doi: 10.1002/eji.200838682.

4.

Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling.

Kumanogoh A, Watanabe C, Lee I, Wang X, Shi W, Araki H, Hirata H, Iwahori K, Uchida J, Yasui T, Matsumoto M, Yoshida K, Yakura H, Pan C, Parnes JR, Kikutani H.

Immunity. 2000 Nov;13(5):621-31.

5.

The CD100-CD72 interaction: a novel mechanism of immune regulation.

Kumanogoh A, Kikutani H.

Trends Immunol. 2001 Dec;22(12):670-6. Review.

PMID:
11738997
6.

Enhanced immune responses in transgenic mice expressing a truncated form of the lymphocyte semaphorin CD100.

Watanabe C, Kumanogoh A, Shi W, Suzuki K, Yamada S, Okabe M, Yoshida K, Kikutani H.

J Immunol. 2001 Oct 15;167(8):4321-8.

7.

Requirement for CD100-CD72 interactions in fine-tuning of B-cell antigen receptor signaling and homeostatic maintenance of the B-cell compartment.

Kumanogoh A, Shikina T, Watanabe C, Takegahara N, Suzuki K, Yamamoto M, Takamatsu H, Prasad DV, Mizui M, Toyofuku T, Tamura M, Watanabe D, Parnes JR, Kikutani H.

Int Immunol. 2005 Oct;17(10):1277-82. Epub 2005 Aug 19.

8.

Positive and negative roles of CD72 in B cell function.

Wu HJ, Bondada S.

Immunol Res. 2002;25(2):155-66. Review.

PMID:
11999169
9.

Efficient killing of chronic B-lymphocytic leukemia cells by superantigen-directed T cells.

Wallgren A, Festin R, Gidlöf C, Dohlsten M, Kalland T, Tötterman TH.

Blood. 1993 Aug 15;82(4):1230-8.

10.

Antibodies to adhesion molecules inhibit the lytic function of MHC-unrestricted cytotoxic cells by preventing their activation.

Zarcone D, Viale O, Cerruti G, Tenca C, Malorni W, Arancia G, Iosi F, Galandrini R, Velardi A, Moretta A, et al.

Cell Immunol. 1992 Sep;143(2):389-404.

PMID:
1380897
11.

Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.

Brando C, Mukhopadhyay S, Kovacs E, Medina R, Patel P, Catina TL, Campbell KS, Santoli D.

J Leukoc Biol. 2005 Aug;78(2):359-71. Epub 2005 Jun 3.

12.

CD100 enhances dendritic cell and CD4+ cell activation leading to pathogenetic humoral responses and immune complex glomerulonephritis.

Li M, O'Sullivan KM, Jones LK, Semple T, Kumanogoh A, Kikutani H, Holdsworth SR, Kitching AR.

J Immunol. 2006 Sep 1;177(5):3406-12.

13.

Immune semaphorins: a new area of semaphorin research.

Kumanogoh A, Kikutani H.

J Cell Sci. 2003 Sep 1;116(Pt 17):3463-70. Review.

14.
15.

Semaphorins in interactions between T cells and antigen-presenting cells.

Kikutani H, Kumanogoh A.

Nat Rev Immunol. 2003 Feb;3(2):159-67. Review.

PMID:
12563299
16.

Tumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptors.

Poggi A, Massaro AM, Negrini S, Contini P, Zocchi MR.

J Immunol. 2005 Mar 1;174(5):2653-60.

17.

Enhanced recognition of human NK receptors after influenza virus infection.

Achdout H, Arnon TI, Markel G, Gonen-Gross T, Katz G, Lieberman N, Gazit R, Joseph A, Kedar E, Mandelboim O.

J Immunol. 2003 Jul 15;171(2):915-23.

18.

Role of CD16 (Fc receptor III) and interleukin-2 in the reactivation of natural killer cells after inhibitory target cell contact.

Heiskala M, Ståhls A, Seppälä I, Timonen T.

Nat Immun Cell Growth Regul. 1991;10(5):265-77.

PMID:
1836835
Items per page

Supplemental Content

Write to the Help Desk